Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primaria

Tamayo-Ojeda, Carmen; Parellada-Esquiusb, Neus; Salvador-González, Betlem; Oriol-Torón,  Pilar Ángeles; Rodríguez-Garrido, M. Dolores; Muñoz-Segura, Dolores

doi:http://dx.doi.org/10.1016/j.aprim.2016.07.004

Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primaria

License

Citation

Tamayo-Ojeda C, Parellada-Esquius N, Salvador-González B, Oriol-Torón PA, Rodríguez-Garrido MD, Muñoz-Segura D. Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primaria. Aten Primaria. 2017 Jun - Jul;49(6):351-358. DOI: 10.1016/j.aprim.2016.07.004

Abstract

OBJECTIVE: Knowing compliance with secondary prevention recommendations of stroke in primary care and to identify factors associated with compliance. DESIGN: Multi-centre cross-sectional. SETTING: Health primary care centres in a metropolitan area (944,280 inhabitants). PARTICIPANTS: Patients aged 18years and over with ischemic brain disease diagnosis prior to 6months before the study. MAIN MEASUREMENTS: Clinical history records of demographic variables, risk factors and cardiovascular comorbidity, drugs, blood pressure values (BP), LDL-cholesterol and medical visits by doctor and nurses after the event. Good adherence was considered when BP <140/90 mmHg, LDL-cholesterol <100 mg/dL, smoking abstention and preventive drugs prescription (anti-platelet/anticoagulants, statins and angiotensin-converting-enzyme inhibitors/angiotensin-receptor-antagonists or diuretics) during the last 18months. RESULTS: A total of 21,976 patients, mean age 73.12 years (SD: 12.13), 48% women, 72.7% with stroke. Co-morbidity: hypertension 70.8%, dyslipidemia 55.1%, DM 30.9%, atrial fibrillation 14.1%, ischemic heart disease 13.5%, chronic renal failure 12.5%, heart failure 8.8%, peripheral arterial disease 6.2%, dementia 7.8%. No record was found for smoking in 3.7%, for BP in 3.5% and for LDL in 6.5%. Optimal control: abstention smoking in 3.7%, BP <140/90 in 65.7% and LDL <100 mg/dL in 41.0%. TREATMENT: 86.2% anti-platelet/anticoagulants, 61.3% statins and 61.8% angiotensin-converting-enzyme inhibitors, angiotensin-receptor-antagonists or diuretic. Registration and risk factors control was higher in 66-79years aged and lower in 18-40years aged. CONCLUSIONS: The implementation of clinical guidelines recommendations for stroke prevention in primary care must be improved, especially among younger population. Organizational changes and more active involvement by professionals and strategies against therapeutic inertia must be taken.